Search
Replimune Group Inc
REPLAdd to Watchlist
10.190USD
+0.190+1.90%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
841.41MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
8
analysts
Hold
Current Rating
4.773
Target Price
-52.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Replimune Group Inc
REPL
8
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Replimune Group Inc's price target?
Analysts forecast that Replimune Group Inc's price target is USD 12.00, with the highest forecast at USD 22.00 and the lowest forecast at USD 2.00.
How have Replimune Group IncREPL's recent earnings per share performed?
The market expectation was USD -0.77, while Replimune Group IncREPL's earnings per share (EPS) for the previous quarter was USD -0.90. EPS for the next quarter is expected at USD -0.71.
What is the analyst rating for Replimune Group Inc?
Based on the ratings of Replimune Group Inc's stock from 8 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
